1. Home
  2. SCLXW vs CNOBP Comparison

SCLXW vs CNOBP Comparison

Compare SCLXW & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • CNOBP
  • Stock Information
  • Founded
  • SCLXW N/A
  • CNOBP N/A
  • Country
  • SCLXW United States
  • CNOBP United States
  • Employees
  • SCLXW 111
  • CNOBP 493
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • CNOBP Major Banks
  • Sector
  • SCLXW Health Care
  • CNOBP Finance
  • Exchange
  • SCLXW Nasdaq
  • CNOBP Nasdaq
  • Market Cap
  • SCLXW N/A
  • CNOBP N/A
  • IPO Year
  • SCLXW N/A
  • CNOBP N/A
  • Fundamental
  • Price
  • SCLXW $0.45
  • CNOBP $23.49
  • Analyst Decision
  • SCLXW
  • CNOBP
  • Analyst Count
  • SCLXW 0
  • CNOBP 0
  • Target Price
  • SCLXW N/A
  • CNOBP N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • CNOBP N/A
  • Earning Date
  • SCLXW 03-07-2025
  • CNOBP N/A
  • Dividend Yield
  • SCLXW N/A
  • CNOBP N/A
  • EPS Growth
  • SCLXW N/A
  • CNOBP N/A
  • EPS
  • SCLXW N/A
  • CNOBP N/A
  • Revenue
  • SCLXW $55,152,000.00
  • CNOBP N/A
  • Revenue This Year
  • SCLXW N/A
  • CNOBP N/A
  • Revenue Next Year
  • SCLXW N/A
  • CNOBP N/A
  • P/E Ratio
  • SCLXW N/A
  • CNOBP N/A
  • Revenue Growth
  • SCLXW 22.02
  • CNOBP N/A
  • 52 Week Low
  • SCLXW $0.18
  • CNOBP N/A
  • 52 Week High
  • SCLXW $0.18
  • CNOBP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW N/A
  • CNOBP 50.82
  • Support Level
  • SCLXW N/A
  • CNOBP $23.11
  • Resistance Level
  • SCLXW N/A
  • CNOBP $23.59
  • Average True Range (ATR)
  • SCLXW 0.00
  • CNOBP 0.20
  • MACD
  • SCLXW 0.00
  • CNOBP -0.04
  • Stochastic Oscillator
  • SCLXW 0.00
  • CNOBP 70.02

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: